Amphotericin B is used increasingly in high-risk patients with profound neutropenia and suspected sepsis. We have observed serious pulmonary reactions characterized by acute dyspnea, hypoxemia, and interstitial infiltrates on chest films in patients receiving amphotericin B and leukocyte transfusions. We reviewed 6 1/2 years of experience at the National Institutes of Health to determine whether this combination was associated with pulmonary toxicity not characteristic of either therapy alone. Amphotericin was used during 22 of 57 leukocyte-transfusion courses. Acute respiratory deterioration occurred during 14 (64 per cent) of these courses but in only two (6 per cent) of 35 courses without amphotericin (P less than 0.01). In seven cases, respiratory deterioration began during or immediately after amphotericin infusion, and it contributed to death in five patients. Diffuse intraalveolar hemorrhage was found when lung biopsy or autopsy was performed. Acute respiratory deterioration was not observed in comparably neutropenic patients given amphotericin but not leukocyte transfusions during the same period. It was mot common when amphotericin was begun with or after institution of daily leukocyte transfusions. Leukocyte transfusions may cause changes in the lungs that amplify the acute toxicity of amphotericin, thereby permitting severe pulmonary reactions.
This article has been cited by other articles:
Tokita, K., Uchida, Y., Yamamoto, T.
(2006). Roles of leukocytosis and cysteinyl leukotriene in polymorphonuclear leukocyte-dependent plasma extravasation. J. Leukoc. Biol.
80: 1308-1319
[Abstract][Full Text]
Brown, J.
(2005). Zygomycosis: An emerging fungal infection. Am J Health Syst Pharm
62: 2593-2596
[Abstract][Full Text]
Sulis, M. L., Van de Ven, C., Henderson, T., Anderson, L., Cairo, M. S.
(2002). Liposomal amphotericin B (AmBisome) compared with amphotericin B {+/-} FMLP induces significantly less in vitro neutrophil aggregation with granulocyte-colony-stimulating factor/dexamethasone-mobilized allogeneic donor neutrophils. Blood
99: 384-386
[Abstract][Full Text]
Kudoh, T., Suzuki, N., Hatakeyama, N., Mizue, N., Hori, T., Oda, T., Watanabe, J., Imamura, M., Chiba, S.
(2001). Successful Unrelated Cord Blood Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pulmonary Aspergillosis Treated by Anti-fungal Therapy, Granulocyte Colony-stimulating Factor-mobilized Granulocytes and Surgical Resection: Case Report. Jpn J Clin Oncol
31: 290-293
[Abstract][Full Text]
Price, T. H., Bowden, R. A., Boeckh, M., Bux, J., Nelson, K., Liles, W. C., Dale, D. C.
(2000). Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood
95: 3302-3309
[Abstract][Full Text]
Adkins, D. R., Goodnough, L. T., Shenoy, S., Brown, R., Moellering, J., Khoury, H., Vij, R., DiPersio, J.
(2000). Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood
95: 3605-3612
[Abstract][Full Text]
Shorr, A. F., Moores, L. K., Edenfield, W. J., Christie, R. J., Fitzpatrick, T. M.
(1999). Mechanical Ventilation in Hematopoietic Stem Cell Transplantation: Can We Effectively Predict Outcomes?. Chest
116: 1012-1018
[Abstract][Full Text]
Schöffski, P., Freund, M., Wunder, R, Petersen, D, Köhne, C H, Hecker, H, Schubert, U, Ganser, A
(1998). Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study. BMJ
317: 379-384
[Abstract][Full Text]
Higgins, M. J., Klein, H. G.
(1989). Massive Transfusion in the Intensive Care Unit. J Intensive Care Med
4: 221-233
[Abstract]
Shannon, K. M., Cowan, M. J., Matthay, K. K.
(1987). Pediatric Bone Marrow Transplantation: Intensive Care Management. J Intensive Care Med
2: 328-344
[Abstract]
